Elham Shahraki

Elham Shahraki

Auto-generated profile, based on publicly available information

Elham Shahraki

Genetics of Non-Communicable Disease Research Center, Department of Nephrology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2022 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
RHRazieh Hosseini
Razieh Hosseini
MKMansour Karajibani
Mansour Karajibani
FMFarzaneh Montazerifar
Farzaneh Montazerifar
ESElham Shahraki
Elham Shahraki
KBKhatereh Babakhani
Khatereh Babakhani
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar
Purpose There is little information about the association between zinc sulfate (ZnSO4) supplementation and metabolic profiles in zinc-deficient diabetic patients on hemodialysis (DHPs). Therefore, we aimed to investigate the association between ZnSO4 supplementation and serum levels of galectin-3 (Gal-3) and cardiometabolic parameters in zinc-deficient DHPs. Methods In the present randomized double-blind placebo-controlled clinical trial, 46 zinc-deficient DHPs (35–62 years) were included and assigned to receive either 220 mg/d ZnSO4 or placebo for 8 weeks. Serum levels of Gal-3, lipid profile, and blood pressure (BP) were assessed at baseline and the end of trial. Results We found a significant effect of ZnSO4 intake on the reduction of serum Gal-3 (P = < 0.001), triglycerides (P = < 0.001), total cholesterol (P = < 0.001), low-density lipoprotein cholesterol (P = < 0.001) and increased high-density lipoprotein cholesterol (P = < 0.001) as compared to the control group. Additionally, systolic blood pressure (SBP) (P = 0.006) and diastolic blood pressure (DBP) (P = 0.01) were significantly reduced following 8 weeks of ZnSO4 supplementation. Conclusion Taken together, 220 mg ZnSO4 supplementation per day for 8 weeks among zinc-deficient DHPs had beneficial effects on Gal-3 and metabolic profiles. Iranian Registry of Clinical Trials Identifier IRCT20191217045765N1, date of registration: 2020–02-09.


1 October 2024 in Research on Animal Production
Verified
Journal Article
Closed access
ESEbrahim Shahraki
Ebrahim Shahraki
MFMohmmad Kazemi Fard
Mohmmad Kazemi Fard
MRMansour Rezaei
Mansour Rezaei
ZPZarbakht Ansari Pirsarai
Zarbakht Ansari Pirsarai
MBMahmoud Barani
Mahmoud Barani